With multidisciplinary oncologic and surgical care, bioprosthetic valves in CHD patients can demonstrate exceptional durability (17 years), offering prolonged survival and quality of life.
Lin et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: